Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Guzzo

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
The British Journal of Dermatology|July 17, 2008
Infliximab improves health-related quality of life in the presence of comorbidities among patients with moderate-to-severe psoriasisS R Feldman, A B Gottlieb, M Bala, et al.
Journal of Clinical Pharmacology|September 1, 1995
Efficacy and pharmacokinetics of two formulations of cyclosporine A in patients with psoriasisC A Elder, M Moore, C T Chang, et al.
The British Journal of Dermatology|February 24, 2012
Long-term efficacy of ustekinumab in patients with moderate-to-severe psoriasis: results from the PHOENIX 1 trial through up to 3 yearsA B Kimball, K B Gordon, S Fakharzadeh, et al.
The British Journal of Dermatology|February 22, 2011
Cardiovascular safety of ustekinumab in patients with moderate to severe psoriasis: results of integrated analyses of data from phase II and III clinical studiesK Reich, R G Langley, M Lebwohl, et al.
Journal of the American Academy of Dermatology|November 17, 2001
A multicenter dose-escalation trial with denileukin diftitox (ONTAK, DAB(389)IL-2) in patients with severe psoriasisA Martin, E Gutierrez, J Muglia, et al.
The British Journal of Dermatology|May 13, 2005
Infliximab treatment results in significant improvement in the quality of life of patients with severe psoriasis: a double-blind placebo-controlled trialS R Feldman, K B Gordon, M Bala, et al.
The British Journal of Dermatology|May 18, 2006
Improvement in quality of life with infliximab induction and maintenance therapy in patients with moderate-to-severe psoriasis: a randomized controlled trialK Reich, F O Nestle, K Papp, et al.
Archives of Dermatology|February 5, 1998
The safety and efficacy of tazarotene gel, a topical acetylenic retinoid, in the treatment of psoriasisG G Krueger, L A Drake, P M Elias, et al.
Current Drug Metabolism|December 29, 2005
Pharmacokinetics of dihydroergocristine and its major metabolite 8'-hydroxy-dihydroergocristine in human plasmaBeatriz Bicalho, Giovanni C Guzzo, Sergio Lilla, et al.
Alimentary Pharmacology & Therapeutics|June 30, 2015
Randomised clinical trial: a placebo-controlled study of intravenous golimumab induction therapy for ulcerative colitisP Rutgeerts, B G Feagan, C W Marano, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
The British Journal of Dermatology|July 17, 2008
Infliximab improves health-related quality of life in the presence of comorbidities among patients with moderate-to-severe psoriasisS R Feldman, A B Gottlieb, M Bala, et al.
Journal of Clinical Pharmacology|September 1, 1995
Efficacy and pharmacokinetics of two formulations of cyclosporine A in patients with psoriasisC A Elder, M Moore, C T Chang, et al.
The British Journal of Dermatology|February 24, 2012
Long-term efficacy of ustekinumab in patients with moderate-to-severe psoriasis: results from the PHOENIX 1 trial through up to 3 yearsA B Kimball, K B Gordon, S Fakharzadeh, et al.
The British Journal of Dermatology|February 22, 2011
Cardiovascular safety of ustekinumab in patients with moderate to severe psoriasis: results of integrated analyses of data from phase II and III clinical studiesK Reich, R G Langley, M Lebwohl, et al.
Journal of the American Academy of Dermatology|November 17, 2001
A multicenter dose-escalation trial with denileukin diftitox (ONTAK, DAB(389)IL-2) in patients with severe psoriasisA Martin, E Gutierrez, J Muglia, et al.
The British Journal of Dermatology|May 13, 2005
Infliximab treatment results in significant improvement in the quality of life of patients with severe psoriasis: a double-blind placebo-controlled trialS R Feldman, K B Gordon, M Bala, et al.
The British Journal of Dermatology|May 18, 2006
Improvement in quality of life with infliximab induction and maintenance therapy in patients with moderate-to-severe psoriasis: a randomized controlled trialK Reich, F O Nestle, K Papp, et al.
Archives of Dermatology|February 5, 1998
The safety and efficacy of tazarotene gel, a topical acetylenic retinoid, in the treatment of psoriasisG G Krueger, L A Drake, P M Elias, et al.
Current Drug Metabolism|December 29, 2005
Pharmacokinetics of dihydroergocristine and its major metabolite 8'-hydroxy-dihydroergocristine in human plasmaBeatriz Bicalho, Giovanni C Guzzo, Sergio Lilla, et al.
Alimentary Pharmacology & Therapeutics|June 30, 2015
Randomised clinical trial: a placebo-controlled study of intravenous golimumab induction therapy for ulcerative colitisP Rutgeerts, B G Feagan, C W Marano, et al.
Pageof 6